Enzo Biochem (NYSE:ENZ) Earns Hold Rating from Analysts at StockNews.com

StockNews.com initiated coverage on shares of Enzo Biochem (NYSE:ENZ) in a report published on Sunday. The firm issued a hold rating on the medical research company’s stock.

Enzo Biochem Trading Up 4.9 %

Shares of NYSE:ENZ opened at $1.08 on Friday. The firm’s 50 day simple moving average is $1.11 and its 200 day simple moving average is $1.11. Enzo Biochem has a fifty-two week low of $0.93 and a fifty-two week high of $1.50.

Enzo Biochem Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, December 2nd. Investors of record on Friday, November 15th will be given a $0.10 dividend. The ex-dividend date of this dividend is Friday, November 15th. This represents a $0.40 dividend on an annualized basis and a dividend yield of 37.04%.

Institutional Trading of Enzo Biochem

A number of hedge funds have recently modified their holdings of ENZ. Geode Capital Management LLC raised its holdings in Enzo Biochem by 3.3% during the 3rd quarter. Geode Capital Management LLC now owns 368,646 shares of the medical research company’s stock worth $413,000 after buying an additional 11,742 shares during the period. XTX Topco Ltd raised its holdings in Enzo Biochem by 94.5% during the 2nd quarter. XTX Topco Ltd now owns 28,262 shares of the medical research company’s stock worth $31,000 after buying an additional 13,735 shares during the period. Renaissance Technologies LLC raised its holdings in Enzo Biochem by 2.6% during the 2nd quarter. Renaissance Technologies LLC now owns 2,499,546 shares of the medical research company’s stock worth $2,725,000 after buying an additional 64,417 shares during the period. Finally, BBR Partners LLC acquired a new stake in Enzo Biochem during the 3rd quarter worth approximately $112,000. 36.90% of the stock is currently owned by institutional investors and hedge funds.

Enzo Biochem Company Profile

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.